Literature DB >> 7081683

Pharmacokinetics and pharmacodynamics of thiopentone, A comparison between young and elderly patients.

J H Christensen, F Andreasen, J A Jansen.   

Abstract

The induction doses of thiopentone in eight elderly male patients (60--80 years) were significantly lower (p less than 0.01) than in eight young male patients (ranges 3.09--5.06 mg/kg body weight in the elderly and 4.88--8.11 mg/kg in the young). The sleep concentrations in venous as well as in arterial blood did not differ between the two groups. In the elderly the arterial concentrations were significantly higher than the venous (p less than 0.05). A three compartment open model was used to describe the disappearance of the drug from the venous blood. Significant increases were found in V3 (means 145.9 and 51.2 litres) and in T 1/2 beta (means 781 and 427 minutes) in the elderly. The redistribution rate constant, k1.2, was decreased in the elderly (p less than 0.05). By impedance cardiography 5 minutes after sleep mean percentages of the pre-induction value of cardiac output were 94.6% in the young and 87.0% in the elderly (p less than 0.05). In the young a correlation was found between cardiac output and induction dose (4 = 0.85, p less than 0.01).

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7081683     DOI: 10.1111/j.1365-2044.1982.tb01148.x

Source DB:  PubMed          Journal:  Anaesthesia        ISSN: 0003-2409            Impact factor:   6.955


  11 in total

Review 1.  The phenomenon and rationale of marked dependence of drug concentration on blood sampling site. Implications in pharmacokinetics, pharmacodynamics, toxicology and therapeutics (Part II).

Authors:  W L Chiou
Journal:  Clin Pharmacokinet       Date:  1989-10       Impact factor: 6.447

Review 2.  Intravenous anaesthetic agents. Pharmacokinetic-pharmacodynamic relationships.

Authors:  B N Swerdlow; F O Holley
Journal:  Clin Pharmacokinet       Date:  1987-02       Impact factor: 6.447

3.  The pharmacokinetics of frusemide are influenced by age.

Authors:  F Andreasen; U Hansen; S E Husted; J A Jansen
Journal:  Br J Clin Pharmacol       Date:  1983-10       Impact factor: 4.335

Review 4.  Pharmacodynamics and pharmacokinetics of thiopental.

Authors:  H Russo; F Bressolle
Journal:  Clin Pharmacokinet       Date:  1998-08       Impact factor: 6.447

5.  Pharmacokinetics of thiopental after single and multiple intravenous doses in critical care patients.

Authors:  H Russo; J Brès; M P Duboin; B Roquefeuil
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

Review 6.  Clinical pharmacokinetic considerations in the treatment of increased intracranial pressure.

Authors:  G Heinemeyer
Journal:  Clin Pharmacokinet       Date:  1987-07       Impact factor: 6.447

Review 7.  Drug therapy and the older person: role of the pharmacist.

Authors:  M J Denham; N L Barnett
Journal:  Drug Saf       Date:  1998-10       Impact factor: 5.606

8.  Variability of thiopental clearance in routine critical care patients.

Authors:  H Russo; J Brés; M P Duboin; B Roquefeuil
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

Review 9.  Pharmacokinetic implications for the clinical use of propofol.

Authors:  J Kanto; E Gepts
Journal:  Clin Pharmacokinet       Date:  1989-11       Impact factor: 6.447

Review 10.  Clinical pharmacokinetic considerations in the elderly. An update.

Authors:  S Dawling; P Crome
Journal:  Clin Pharmacokinet       Date:  1989-10       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.